Skip to content

Dr. GEYPEN LORE

Active Private limited companyfounded 2022active for 4 yearsVerhavertstraat (Cypriaan) 29, 1500 HalleKBO/BCE: BE 0790.758.945

Lifetime

3 annual accounts with figures on one time axis
peak of €28,779 in 2025
€28,779▲ 54.0%
peak of €17,479 in 2025
€17,479▲ 38.7%
peak of €42,786 in 2025
€42,786▲ 69.1%
€478▼ 93.0%
Board1 name since 2022
1 director
Documentsfilings and deeds
13-07-202618 days before the deadline
2025micro format
Gross margin from €18,688 to €28,779Result from €12,604 to €17,479Equity from €25,307 to €42,786Debts from €6,830 to €478Cash from €4,623 to €20,714

Key points

from the 2025 annual accounts

Turnover

≈ €89,000 estimated

The micro format states no turnover.

Liquidity

60.89 was 1.94 in 2024

Short-term debts fell from €6,830 to €478.

Position in the sector

98.9%

Higher solvency than 95% of companies in human health. Sector median 63.1% · 21,368 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Dr. GEYPEN LORE has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for Dr. GEYPEN LORE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 13-09-2022
  • 100 sharesdeed of 15-09-2022
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:0790758945
General meeting of 06-12-2022 Gazette deed
First establishment Verhavertstraat (Cypriaan) 29, Halle
Incorporation Founding capital of €1,000, 100 shares · Founded by · appointed as director · published on 15-09-2022 · Gazette deed
All 9 events

Comparable companies

same main activity, similar in size and age
Company
Dr. GEYPEN LORE Halle €43,264 €28,779 98.9% -
CAVASTA MEDICAL Profondeville €39,713 €28,617 83.8% -
GIRISHYA Eghezée €37,493 €28,937 -53.5% -
BTCW Namur €51,749 €29,024 83.0% -
Dr Sorée Natacha Médimosaique Brussels €51,074 €30,734 33.7% -
Dr. Sofie De Smet Bruges €40,320 €33,631 7.1% -
HENRYA Woluwe-Saint-Lambert €36,656 €25,848 66.6% -

These companies have the same main activity as Dr. GEYPEN LORE: general medical practice (NACE 86210). They are comparable in size and age: total assets between €36,700 and €51,700, founded between 2021 and 2023.

Official details

Source: KBO
Status
Active since 13-09-2022Normal situation
Activity
General medical practiceNACE 86210
Establishment unit
2.335.938.8551500 Halle, since 01-01-2023
Financial year end
31 December
Peppol
Reachable since 12-10-2024
Company details

Annual accounts 2025

€43,264▲ 34.6%
Filing
Filed on 13-07-2026, 18 days before the end of the filing period
Financials

Insights on Dr. GEYPEN LORE

Dr. GEYPEN LORE files the micro format. That format states no turnover. The gross margin rose from €16,502 in 2023 to €28,779 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. GEYPEN LORE

What is the company number of Dr. GEYPEN LORE?
The company number of Dr. GEYPEN LORE is 0790.758.945. The VAT number is the same number with BE in front: BE 0790.758.945.
Where is Dr. GEYPEN LORE based?
The registered office is at Verhavertstraat (Cypriaan) 29, 1500 Halle.Company details
What does Dr. GEYPEN LORE do?
According to the KBO register, the main activity is general medical practice (NACE 86210).
What is the legal form of Dr. GEYPEN LORE?
Dr. GEYPEN LORE is a private limited company (BV).
When was Dr. GEYPEN LORE founded?
Dr. GEYPEN LORE was founded on 13-09-2022.
Is Dr. GEYPEN LORE still active?
Yes, Dr. GEYPEN LORE is an active enterprise in the KBO register.
What is the turnover of Dr. GEYPEN LORE?
The turnover in financial year 2025 is ≈ €89,000. This figure is estimated from the gross margin of €28,779 and 47 comparable companies (NACE 86). It probably lies between €64,000 and €120,000.Financials
Is Dr. GEYPEN LORE profitable?
In financial year 2025, Dr. GEYPEN LORE made a profit of €17,479.
Where can I find the annual accounts of Dr. GEYPEN LORE?
Dr. GEYPEN LORE filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. GEYPEN LORE due?
Dr. GEYPEN LORE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.